Table: Aska Pharmaceutical -6-MTH group results

ASKA Pharmaceutical Holdings

04/11/2015 07:00

Nov 4 (Reuters)-  
             Aska Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 6 months ended      6 months ended       Year to  
                Sep 30, 2015        Sep 30, 2014     Mar 31, 2016  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             21.11               23.20            44.00     
                 (-9.0 pct)          (+15.8 pct)      (+2.5 pct)   
  Operating        506 mln               1.07           800 mln    
                 (-52.6 pct)         (+50.6 pct)      (-43.9 pct)  
  Recurring        688 mln               1.18             1.00     
                 (-41.5 pct)         (+39.9 pct)      (-41.9 pct)  
  Net              395 mln             836 mln          600 mln    
                 (-52.6 pct)         (+60.0 pct)      (-49.7 pct)  
  EPS             14.21 yen           30.05 yen        21.53 yen   
  Ann Div                             14.00 yen        14.00 yen   
  -Q2 div         7.00 yen            7.00 yen                     
  -Q4 div                             7.00 yen         7.00 yen    
   
  NOTE - Aska Pharmaceutical Co Ltd makes hormonal and intestinal medicines.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4514.T  
  ((Tokyo Headline News Desk +813 6441 1812))